Background
We recognise that some GP practices are considering opting out of the Seasonal Flu Vaccination Enhanced Service. Historically, this has been uncommon; however, given the significant challenges currently facing practices, it is an important moment to provide clear guidance. While it is essential to deliver high-quality patient care, practices must carefully assess their financial viability and sustainability. This guidance is designed to support practices in making informed decisions, emphasising the importance of evaluating the overall financial impact of participation.
Key Considerations
Contractual and Regulatory Responsibilities
If a practice decides to opt out, the following points should be noted:
Practices must reasonably cooperate with relevant stakeholders (e.g., NHS England, local authorities, and integrated care boards) to:
- Understand vaccine uptake and barriers.
- Assist in strategy development to improve vaccination rates, where applicable.
If requested, practices may need to provide relevant data (e.g., patient eligibility, housebound status, contraindications) to other service providers. However, this does not extend to performing activities beyond the scope of reasonable cooperation.
Communication with the Integrated Care Board (ICB)
Should your practice choose to step back from the Enhanced Service, it is advisable to inform the ICB, providing a rationale for your decision. This helps maintain transparency and aids the ICB in planning alternative arrangements.
Next steps
For practices uncertain about their course of action:
- Conduct a detailed financial review of the programme.
- Engage with your Local Medical Committee medical director for tailored advice.
- Inform the ICB of your considerations and seek their perspective on support and delivery options.
Your LMC remains available to assist with queries, including interpreting regulatory obligations or facilitating communication with stakeholders.
We are here to help
For further assistance, contact the LMC office or reach out directly to your regional medical director.
Note: This guidance is informational and does not constitute legal or financial advice.